Article
Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial
Rating:
0.0
Views:
54
Likes:
1
Library:
1
Bristol Myers Squibb said on Thursday the injectable form of its blockbuster cancer drug Opdivo met the main goal in trial that had patients with a type of kidney cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value